Table 1 Clinical characteristics of eligible patients
From: Proton pump inhibitor chemosensitization in human osteosarcoma: from the bench to the patients’ bed
Variable | No (%) | |
|---|---|---|
Gender | Male | 59 (60%) |
Female | 39 (40%) | |
Site | Femur | 49 (50%) |
Tibia | 33 (34%) | |
Humerus | 8 (8%) | |
Other | 8 (8%) | |
SAP | High | 26 (26%) |
Normal | 72 (74%) | |
LDH | High | 22 (22%) |
Normal | 76 (78%) | |
Histology | Osteoblastic | 65 (66%) |
Chondroblastic | 18 (18%) | |
Telangiectatic | 10 (10%) | |
Fibroblastic | 5 (5%) |